These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1406233)

  • 1. Chronic cyclosporin A therapy in rats.
    Midha R; Mackinnon SE; Wade JA; Evans PJ; Best TJ; Wong PY
    Microsurgery; 1992; 13(5):273-6. PubMed ID: 1406233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats.
    Vallelado AI; López MI; Calonge M; Sánchez A; Alonso MJ
    Curr Eye Res; 2002 Jan; 24(1):39-45. PubMed ID: 12187493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
    Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
    Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus (rapamycin, Rapamune) and combination therapy with cyclosporin A in the rat developing adjuvant arthritis model: correlation with blood levels and the effects of different oral formulations.
    Carlson RP; Hartman DA; Ochalski SJ; Zimmerman JL; Glaser KB
    Inflamm Res; 1998 Aug; 47(8):339-44. PubMed ID: 9754868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between total kidney cyclosporin A concentrations, trough drug levels and renal function in the rat following withdrawal of treatment.
    Mead JC; Brown PA; Whiting PH
    Hum Exp Toxicol; 1994 Jul; 13(7):506-11. PubMed ID: 7917509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
    Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
    Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended survival and function of peripheral nerve allografts after cessation of long-term cyclosporin administration in rats.
    Frazier J; Yu L; Rhee E; Shaw L; LaRossa D; Rostami A
    J Hand Surg Am; 1993 Jan; 18(1):100-6. PubMed ID: 8423292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine dose, serum trough levels, and allograft preservation in a rat model of laryngeal transplantation.
    Haug M; Dan O; Wimberley S; Fritz M; Lorenz RR; Strome M
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):506-10. PubMed ID: 12834117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage.
    Wassef R; Cohen Z; Langer B
    Transplantation; 1985 Nov; 40(5):489-93. PubMed ID: 3877356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival.
    Tchervenkov JI; Epstein MD; Alexander JW; Schroeder TJ
    Transplantation; 1989 Jan; 47(1):177-81. PubMed ID: 2643225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Sass DA; Rucinski B; Bryer HP; Mann GN; Yuan Z; Ma Y; Jee WS; Epstein S
    Bone; 1996 Oct; 19(4):381-6. PubMed ID: 8894144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cyclosporin-A in experimental spinal cord injury: design of a dosing strategy to maintain therapeutic levels.
    Ibarra A; Reyes J; Martínez S; Correa D; Guízar-Sahagún G; Grijalva I; Castañeda-Hernández G; Flores-Murrieta FJ; Franco-Bourland R; Madrazo I
    J Neurotrauma; 1996 Oct; 13(10):569-72. PubMed ID: 8915908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
    van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
    Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine.
    Vadiei K; Lopez-Berestein G; Perez-Soler R; Luke DR
    Drug Metab Dispos; 1991; 19(6):1147-51. PubMed ID: 1687023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous injection of oral cyclosporin A solution.
    Midha R; Mackinnon SE; Evans PJ; Best TJ; Wong PY
    Microsurgery; 1992; 13(2):92-4. PubMed ID: 1569886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dosing-time dependent influence of chronic cyclosporin A treatment on daily profiles of plasma glucose and insulin in the Wistar rat.
    Malmary MF; Moussamih-Kettani S; Labat C; Oustrin J; Houin G
    Chronobiol Int; 1997 May; 14(3):275-85. PubMed ID: 9167888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.